Report cover image

Global Montelukast Sodium Granules Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 197 Pages
SKU # APRC20278828

Description

Summary

According to APO Research, the global Montelukast Sodium Granules market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Montelukast Sodium Granules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Montelukast Sodium Granules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Montelukast Sodium Granules market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Montelukast Sodium Granules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Montelukast Sodium Granules market include Teva Pharmaceutical Industries, Organon LLC, Novartis, Hengrui Medicine, Hybio Pharmaceutical, Pfizer, Mylan Pharmaceuticals, Luye Pharma Group and Dr. Reddy's Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Montelukast Sodium Granules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Montelukast Sodium Granules, also provides the sales of main regions and countries. Of the upcoming market potential for Montelukast Sodium Granules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Montelukast Sodium Granules sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Montelukast Sodium Granules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Montelukast Sodium Granules sales, projected growth trends, production technology, application and end-user industry.


Montelukast Sodium Granules Segment by Company


Teva Pharmaceutical Industries

Organon LLC

Novartis

Hengrui Medicine

Hybio Pharmaceutical

Pfizer

Mylan Pharmaceuticals

Luye Pharma Group

Dr. Reddy's Laboratories

Dong-A ST

Montelukast Sodium Granules Segment by Type


5mg

10mg

Montelukast Sodium Granules Segment by Application


Hospital

Clinic

Others

Montelukast Sodium Granules Segment by Region


North America


United States

Canada

Mexico

Europe


Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific


China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America


Brazil

Argentina

Chile

Colombia

Middle East & Africa


Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Montelukast Sodium Granules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Montelukast Sodium Granules market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Montelukast Sodium Granules significant trends, drivers, influence factors in global and regions.
6. To analyze Montelukast Sodium Granules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium Granules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Montelukast Sodium Granules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Montelukast Sodium Granules industry.
Chapter 3: Detailed analysis of Montelukast Sodium Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Montelukast Sodium Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Montelukast Sodium Granules in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Montelukast Sodium Granules Sales Value (2020-2031)
1.2.2 Global Montelukast Sodium Granules Sales Volume (2020-2031)
1.2.3 Global Montelukast Sodium Granules Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Montelukast Sodium Granules Market Dynamics
2.1 Montelukast Sodium Granules Industry Trends
2.2 Montelukast Sodium Granules Industry Drivers
2.3 Montelukast Sodium Granules Industry Opportunities and Challenges
2.4 Montelukast Sodium Granules Industry Restraints
3 Montelukast Sodium Granules Market by Company
3.1 Global Montelukast Sodium Granules Company Revenue Ranking in 2024
3.2 Global Montelukast Sodium Granules Revenue by Company (2020-2025)
3.3 Global Montelukast Sodium Granules Sales Volume by Company (2020-2025)
3.4 Global Montelukast Sodium Granules Average Price by Company (2020-2025)
3.5 Global Montelukast Sodium Granules Company Ranking (2023-2025)
3.6 Global Montelukast Sodium Granules Company Manufacturing Base and Headquarters
3.7 Global Montelukast Sodium Granules Company Product Type and Application
3.8 Global Montelukast Sodium Granules Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Montelukast Sodium Granules Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Montelukast Sodium Granules Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Montelukast Sodium Granules Market by Type
4.1 Montelukast Sodium Granules Type Introduction
4.1.1 5mg
4.1.2 10mg
4.2 Global Montelukast Sodium Granules Sales Volume by Type
4.2.1 Global Montelukast Sodium Granules Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Montelukast Sodium Granules Sales Volume by Type (2020-2031)
4.2.3 Global Montelukast Sodium Granules Sales Volume Share by Type (2020-2031)
4.3 Global Montelukast Sodium Granules Sales Value by Type
4.3.1 Global Montelukast Sodium Granules Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Montelukast Sodium Granules Sales Value by Type (2020-2031)
4.3.3 Global Montelukast Sodium Granules Sales Value Share by Type (2020-2031)
5 Montelukast Sodium Granules Market by Application
5.1 Montelukast Sodium Granules Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Others
5.2 Global Montelukast Sodium Granules Sales Volume by Application
5.2.1 Global Montelukast Sodium Granules Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Montelukast Sodium Granules Sales Volume by Application (2020-2031)
5.2.3 Global Montelukast Sodium Granules Sales Volume Share by Application (2020-2031)
5.3 Global Montelukast Sodium Granules Sales Value by Application
5.3.1 Global Montelukast Sodium Granules Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Montelukast Sodium Granules Sales Value by Application (2020-2031)
5.3.3 Global Montelukast Sodium Granules Sales Value Share by Application (2020-2031)
6 Montelukast Sodium Granules Regional Sales and Value Analysis
6.1 Global Montelukast Sodium Granules Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Montelukast Sodium Granules Sales by Region (2020-2031)
6.2.1 Global Montelukast Sodium Granules Sales by Region: 2020-2025
6.2.2 Global Montelukast Sodium Granules Sales by Region (2026-2031)
6.3 Global Montelukast Sodium Granules Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Montelukast Sodium Granules Sales Value by Region (2020-2031)
6.4.1 Global Montelukast Sodium Granules Sales Value by Region: 2020-2025
6.4.2 Global Montelukast Sodium Granules Sales Value by Region (2026-2031)
6.5 Global Montelukast Sodium Granules Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Montelukast Sodium Granules Sales Value (2020-2031)
6.6.2 North America Montelukast Sodium Granules Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Montelukast Sodium Granules Sales Value (2020-2031)
6.7.2 Europe Montelukast Sodium Granules Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Montelukast Sodium Granules Sales Value (2020-2031)
6.8.2 Asia-Pacific Montelukast Sodium Granules Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Montelukast Sodium Granules Sales Value (2020-2031)
6.9.2 South America Montelukast Sodium Granules Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Montelukast Sodium Granules Sales Value (2020-2031)
6.10.2 Middle East & Africa Montelukast Sodium Granules Sales Value Share by Country, 2024 VS 2031
7 Montelukast Sodium Granules Country-level Sales and Value Analysis
7.1 Global Montelukast Sodium Granules Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Montelukast Sodium Granules Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Montelukast Sodium Granules Sales by Country (2020-2031)
7.3.1 Global Montelukast Sodium Granules Sales by Country (2020-2025)
7.3.2 Global Montelukast Sodium Granules Sales by Country (2026-2031)
7.4 Global Montelukast Sodium Granules Sales Value by Country (2020-2031)
7.4.1 Global Montelukast Sodium Granules Sales Value by Country (2020-2025)
7.4.2 Global Montelukast Sodium Granules Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.5.2 USA Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.6.2 Canada Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.8.2 Germany Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.9.2 France Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.9.3 France Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.11.2 Italy Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.12.2 Spain Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.13.2 Russia Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.16.2 China Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.16.3 China Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.17.2 Japan Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.19.2 India Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.19.3 India Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.20.2 Australia Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.24.2 Chile Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.26.2 Peru Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.28.2 Israel Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.29.2 UAE Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.31.2 Iran Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Montelukast Sodium Granules Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Montelukast Sodium Granules Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Montelukast Sodium Granules Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Teva Pharmaceutical Industries
8.1.1 Teva Pharmaceutical Industries Comapny Information
8.1.2 Teva Pharmaceutical Industries Business Overview
8.1.3 Teva Pharmaceutical Industries Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.1.4 Teva Pharmaceutical Industries Montelukast Sodium Granules Product Portfolio
8.1.5 Teva Pharmaceutical Industries Recent Developments
8.2 Organon LLC
8.2.1 Organon LLC Comapny Information
8.2.2 Organon LLC Business Overview
8.2.3 Organon LLC Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.2.4 Organon LLC Montelukast Sodium Granules Product Portfolio
8.2.5 Organon LLC Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.3.4 Novartis Montelukast Sodium Granules Product Portfolio
8.3.5 Novartis Recent Developments
8.4 Hengrui Medicine
8.4.1 Hengrui Medicine Comapny Information
8.4.2 Hengrui Medicine Business Overview
8.4.3 Hengrui Medicine Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.4.4 Hengrui Medicine Montelukast Sodium Granules Product Portfolio
8.4.5 Hengrui Medicine Recent Developments
8.5 Hybio Pharmaceutical
8.5.1 Hybio Pharmaceutical Comapny Information
8.5.2 Hybio Pharmaceutical Business Overview
8.5.3 Hybio Pharmaceutical Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.5.4 Hybio Pharmaceutical Montelukast Sodium Granules Product Portfolio
8.5.5 Hybio Pharmaceutical Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.6.4 Pfizer Montelukast Sodium Granules Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 Mylan Pharmaceuticals
8.7.1 Mylan Pharmaceuticals Comapny Information
8.7.2 Mylan Pharmaceuticals Business Overview
8.7.3 Mylan Pharmaceuticals Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.7.4 Mylan Pharmaceuticals Montelukast Sodium Granules Product Portfolio
8.7.5 Mylan Pharmaceuticals Recent Developments
8.8 Luye Pharma Group
8.8.1 Luye Pharma Group Comapny Information
8.8.2 Luye Pharma Group Business Overview
8.8.3 Luye Pharma Group Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.8.4 Luye Pharma Group Montelukast Sodium Granules Product Portfolio
8.8.5 Luye Pharma Group Recent Developments
8.9 Dr. Reddy's Laboratories
8.9.1 Dr. Reddy's Laboratories Comapny Information
8.9.2 Dr. Reddy's Laboratories Business Overview
8.9.3 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.9.4 Dr. Reddy's Laboratories Montelukast Sodium Granules Product Portfolio
8.9.5 Dr. Reddy's Laboratories Recent Developments
8.10 Dong-A ST
8.10.1 Dong-A ST Comapny Information
8.10.2 Dong-A ST Business Overview
8.10.3 Dong-A ST Montelukast Sodium Granules Sales, Value and Gross Margin (2020-2025)
8.10.4 Dong-A ST Montelukast Sodium Granules Product Portfolio
8.10.5 Dong-A ST Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Montelukast Sodium Granules Value Chain Analysis
9.1.1 Montelukast Sodium Granules Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Montelukast Sodium Granules Sales Mode & Process
9.2 Montelukast Sodium Granules Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Montelukast Sodium Granules Distributors
9.2.3 Montelukast Sodium Granules Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.